Value of Schwangerschaftsprotein 1 (SP1) and pregnancy-associated plasma protein-A (PAPP-A) in the clinical management of threatened abortion

This publication has 9 references indexed in Scilit:

• Use of a rapid radioimmunoassay for pregnancy-specific beta-1 glycoprotein in gynecologic emergencies: Comparison with routine urinary pregnancy test and a rapid radioimmunoassay for human chorionic gonadotropin
  American Journal of Obstetrics and Gynecology, 1981
• Pregnancy-specific β1-glycoprotein as a prognostic indicator in complications of early pregnancy
  American Journal of Obstetrics and Gynecology, 1980
• The variable influence of an α component in pregnancy plasma on four different assay systems for the measurement of pregnancy-specific β1 glycoprotein
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1980
• THE RADIOIMMUNOASSAY OF A PREGNANCY SPECIFIC‐β₁‐GLYCOPROTEIN IN PLASMA AS A PREGNANCY TEST FOR SUBFERTILE WOMEN
  BJOG: An International Journal of Obstetrics and Gynaecology, 1980
• A STUDY OF INVESTIGATIONS USED TO PREDICT OUTCOME OF PREGNANCY AFTER THREATENED ABORTION
  BJOG: An International Journal of Obstetrics and Gynaecology, 1980
• Clinical and Ultrasonic Aspects in the Diagnosis and Follow-Up of Patients with Early Pregnancy Failure
  Acta Obstetricia et Gynecologica Scandinavica, 1980
• PLASMA PREGNANCY‐SPECIFIC β‐GLYCOPROTEIN IN COMPLICATIONS OF EARLY PREGNANCY
  BJOG: An International Journal of Obstetrics and Gynaecology, 1978
• The predictive value of pregnancy-specific β1-glycoprotein (SP1) in threatened abortion
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1978
• IS MEASUREMENT OF PLACENTAL FUNCTION AND MATERNAL WEIGHT WORTH WHILE?
  The Lancet, 1978